Cantor Fitzgerald upgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Sell to Hold with a price target of $54.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE